Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure

References

• ChenJ, NormandS-LT, WangY, KrumholzHM. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998–2008. JAMA. 2011;306(15):1669–1678. doi:10.1001/jama.2011.147422009099
   PubMed Web of Science ®Google Scholar
• BleuminkGS, KnetschAM, SturkenboomMCJM, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J. 2004;25(18):1614–1619. doi:10.1016/j.ehj.2004.06.03815351160
   PubMed Web of Science ®Google Scholar
• PocockSJ, WangD, PfefferMA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27(1):65–75. doi:10.1093/eurheartj/ehi55516219658
   PubMed Web of Science ®Google Scholar
• Siirilä-WarisK, LassusJ, MelinJ, PeuhkurinenK, NieminenMS, HarjolaV-P. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure. Eur Heart J. 2006;27(24):3011–3017. doi:10.1093/eurheartj/ehl40717127708
   PubMed Web of Science ®Google Scholar
• PonikowskiP, VoorsAA, AnkerSD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw12827206819
   PubMed Web of Science ®Google Scholar
• MogensenUM, ErsbøllM, AndersenM, et al. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Heart Fail. 2011;13(11):1216–1223. doi:10.1093/eurjhf/hfr11621896536
   PubMed Web of Science ®Google Scholar
• BarsheshetA, ShotanA, CohenE, et al. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Fail. 2010;12(8):833–840. doi:10.1093/eurjhf/hfq07920494926
   PubMed Web of Science ®Google Scholar
• HowlettJG. Should we perform a heart failure risk score?Circ Heart Fail. 2013;6(1):4–5. doi:10.1161/CIRCHEARTFAILURE.112.97317223322877
   PubMed Web of Science ®Google Scholar
• AlbaAC, AgoritsasT, JankowskiM, et al. Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail. 2013;6(5):881–889. doi:10.1161/CIRCHEARTFAILURE.112.00004323888045
   PubMed Web of Science ®Google Scholar
• LevyWC, MozaffarianD, LinkerDT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113(11):1424–1433. doi:10.1161/CIRCULATIONAHA.105.58410216534009
   PubMed Web of Science ®Google Scholar
• PocockSJ, AritiCA, McMurrayJJV, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34(19):1404–1413. doi:10.1093/eurheartj/ehs33723095984
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology of Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of heart failure 2014. Zhonghua Xin Xue Guan Bing Za Zhi. 2014;42(2):98–122.24735621
   PubMedGoogle Scholar
• SawanoM, ShiraishiY, KohsakaS, et al. Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides. ESC Heart Fail. 2018;5(4):610–619. doi:10.1002/ehf2.1227829520978
   PubMed Web of Science ®Google Scholar
• LiS, MarcusP, NúñezJ, NúñezE, SanchisJ, LevyWC. Validity of the Seattle Heart Failure Model after heart failure hospitalization. ESC Heart Fail. 2019;6(3):509–515. doi:10.1002/ehf2.1242730825268
   PubMed Web of Science ®Google Scholar
• Crespo-LeiroMG, AnkerSD, MaggioniAP, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613–625. doi:10.1002/ejhf.56627324686
   PubMed Web of Science ®Google Scholar
• GroenewegenA, RuttenFH, MosterdA, HoesAW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342–1356. doi:10.1002/ejhf.185832483830
   PubMed Web of Science ®Google Scholar
• ManzanoL, BabalisD, RoughtonM, et al. Predictors of clinical outcomes in elderly patients with heart failure. Eur J Heart Fail. 2011;13(5):528–536. doi:10.1093/eurjhf/hfr03021454299
   PubMed Web of Science ®Google Scholar
• SatoM, SakataY, SatoK, et al. Clinical characteristics and prognostic factors in elderly patients with chronic heart failure -A report from the CHART-2 study. Int J Cardiol Heart Vasc. 2020;27:100497. doi:10.1016/j.ijcha.2020.10049732215317
   PubMed Web of Science ®Google Scholar
• TengT-HK, TrompJ, TayWT, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. The Lancet Global Health. 2018;6(9):e1008–e1018. doi:10.1016/S2214-109X(18)30306-130103979
   PubMed Web of Science ®Google Scholar
• FonarowGC, AlbertNM, CurtisAB, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122(6):585–596. doi:10.1161/CIRCULATIONAHA.109.93447120660805
   PubMed Web of Science ®Google Scholar
• KomajdaM, HanonO, HochadelM, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: euro Heart Failure Survey II. Eur Heart J. 2009;30(4):478–486. doi:10.1093/eurheartj/ehn53919106198
   PubMed Web of Science ®Google Scholar
• CanepaM, FonsecaC, ChioncelO, et al. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry. JACC Heart Fail. 2018;6(6):452–462. doi:10.1016/j.jchf.2018.02.00129852929
   PubMed Web of Science ®Google Scholar
• AllenLA, MatlockDD, ShetterlySM, et al. Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart Failure. JAMA Cardiol. 2017;2(4):435–441. doi:10.1001/jamacardio.2016.503628002546
   PubMed Web of Science ®Google Scholar
• FreitasP, AguiarC, FerreiraA, TralhãoA, VentosaA, MendesM. Comparative Analysis of Four Scores to Stratify Patients With Heart Failure and Reduced Ejection Fraction. Am J Cardiol. 2017;120(3):443–449. doi:10.1016/j.amjcard.2017.04.04728629552
   PubMed Web of Science ®Google Scholar
• SartipyU, DahlströmU, EdnerM, LundLH. Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry. Eur J Heart Fail. 2014;16(2):173–179. doi:10.1111/ejhf.3224464911
   PubMed Web of Science ®Google Scholar
• RichJD, BurnsJ, FreedBH, MaurerMS, BurkhoffD, ShahSJ. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018;7(20):e009594. doi:10.1161/JAHA.118.00959430371285
   PubMed Web of Science ®Google Scholar
• KhanamSS, ChoiE, SonJ-W, et al. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure. PLoS One. 2018;13(11):e0206380. doi:10.1371/journal.pone.020638030485284
   PubMed Web of Science ®Google Scholar
• ParkJJ, ChoY-J, OhI-Y, et al. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: an analysis of the Korean Acute Heart Failure registry. Int J Cardiol. 2017;248:239–245. doi:10.1016/j.ijcard.2017.08.00428821416
   PubMed Web of Science ®Google Scholar
• CaugheyMC, AveryCL, NiH, et al. Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance). Am J Cardiol. 2014;114(12):1850–1854. doi:10.1016/j.amjcard.2014.09.02425438912
   PubMed Web of Science ®Google Scholar
• DewanP, JacksonA, JhundPS, et al. The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail. 2020;22(11):2123–2133. doi:10.1002/ejhf.183232353205
   PubMed Web of Science ®Google Scholar
• KajimotoK, MinamiY, OtsuboS, SatoN. Sex Differences in Left Ventricular Cavity Dilation and Outcomes in Acute Heart Failure Patients With Left Ventricular Systolic Dysfunction. Can J Cardiol. 2018;34(4):477–484. doi:10.1016/j.cjca.2018.01.01929571428
   PubMed Web of Science ®Google Scholar
• Vishram-NielsenJKK, ForoutanF, RossHJ, GustafssonF, AlbaAC. Performance of Prognostic Risk Scores in Heart Failure Patients: do Sex Differences Exist?Can J Cardiol. 2020;36(1):45–53. doi:10.1016/j.cjca.2019.08.02131874750
   PubMed Web of Science ®Google Scholar